Search

Author/Creator Shapiro, G I

2. Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors. (23rd February 2018)

Authors:
Italiano, A; Infante, J R; Shapiro, G I; Moore, K N; LoRusso, P M; Hamilton, E; Cousin, S; Toulmonde, M; Postel-Vinay, S; Tolaney, S; Blackwood, E M; Mahrus, S; Peale, F V; Lu, X; Moein, A; Epler, J; DuPree, K; Tagen, M; Murray, E R; Schutzman, J L
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1304
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search